HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Dysgerminoma of the ovary. Presentation of case report].

Abstract
Germ-cell tumors account for about 20% of all ovarian tumors and the dysgerminoma is the most common in this group. The treatment is surgical, followed by chemotherapy and radiotherapy in greater stage than IA. The aim of this article is to present a case report of 18-years-old patient with a left ovary dysgerminoma who had undergone a surgery--left-side ovariectomy. One year later when the patient was pregnant in 6 m.l., retroperitoneal recurrence was diagnosed by ultrasound examination. The patient has completed her pregnancy and delivered by caesarean section. Retroperitoneal recurrence of the same tumor, inoperable at this stage was histologically confirmed during the operation. The treatment continued with two courses of neoadjuvant chemotherapy followed by radical surgery with removal of the whole left kidney and the tumor. After that 2 courses of adjuvant chemotherapy were conducted, followed by prophylactic external beam radiotherapy for retroperitoneal lymph nodes. No data for local recurrences and distant metastases were found during the regular examinations, performed 2 years later. The treatment of dysgerminoma is discussed. This treatment must be complex one and should include radical surgery, chemotherapy and radiotherapy.
AuthorsI Mihaylova, V Parvanova, P Kostova
JournalAkusherstvo i ginekologiia (Akush Ginekol (Sofiia)) Vol. 52 Issue 2 Pg. 56-9 ( 2013) ISSN: 0324-0959 [Print] Bulgaria
PMID23807982 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Adolescent
  • Cesarean Section
  • Chemotherapy, Adjuvant
  • Dysgerminoma (pathology, surgery, therapy)
  • Female
  • Humans
  • Neoplasm Recurrence, Local (pathology, surgery, therapy)
  • Ovarian Neoplasms (pathology, surgery, therapy)
  • Ovariectomy
  • Ovary (pathology, surgery)
  • Pregnancy
  • Pregnancy Complications, Neoplastic (pathology, surgery, therapy)
  • Radiotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: